ThermaFreeze Products Corp (TZPC)

[cameron86]

Wow

[makinezmoney]

$TZPC: $18.90 !!!!!!!!!!


Maybe tomorrow we get our $25 that we've been longing for



Why not ?



Whatta ride its been



GO $TZPC

[makinezmoney]

$TZPC : SEVENTEEN DOLLARS !!!!!!!!!!!!!!!!!!!!!!




HAAAAAAAAAAAAAAAAAAA HA HA HA HA HA HAAAAAAAAAAAAAAAAAAAAAAAAAAAAA



Whats my name ??????????






GO $TZPC

[makinezmoney]

$TZPC: Now 13.40 !!!!!!!!!!



HAAAAAAAAAaaaaaaaaaaaaaaaaa ha ha ha haaaaaaaaaaaaa.


$EMDF is next




GO $TZPC

[Awl416]

10 bucks agin

Unreal

[makinezmoney]

$TZPC: Now hits $11...........


Can you freakin believe this ??????????



WOW !!!!!!!!!!



$NATUF next




GO $TZPC

[makinezmoney]

$TZPC : $25/sh tomorrow ??????????



Say it ain't so.



WOOOOOOOOOOOOOOOOOOOOOO



Lets see it happen




GO $TZPC

[makinezmoney]

$TZPC: Just $0.05 to $10.......... no BIGGIE !!!!!!



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159379671









I told you $NATUF already........ rest is up to you.




GO $TZPC

[Figster]

Dear makin z,

You posted a financial statement from Sep 20 which demonstrated tzpc had minimal revenue. Conversely, the price is shooting up and the volume is pretty steady. You are the only person I have read that offers an explanation...vaccine shipment. Can you link me to any further information?

[makinezmoney]

$TZPC: Back over $4 babyyyyyyyyyyyyyyyyy



GO $TZPC



Lots and lots and lots of vaccines to deliver



GO $TZPC

[makinezmoney]

$TZPC : Quarterly Fins

https://sec.report/otc/financial-report/264199/Thermafreeze-2020-Q3-Financials-and-Notes.pdf

Plan of Operation
We manufacture, distribute, and market high-quality ice packs by way of a patented, solution-based technology for cold chain product management, thermal packaging and therapeutic health care issues, requiring either cold or hot topical application. ThermaFreeze pads are based on a proprietary cooling technology and makes use of non-toxic, biodegradable crystallized polymer capable of absorbing moisture and releasing it in a slow and gradual pace through a process called sublimation. This cooling effect lasts for a while without giving that uncomfortable wetness generally created by ordinary ice and ice substitutes. To continue to operate and grow our business we believe that it is necessary to obtain additional financing. We cannot guarantee that the Company will be obtain additional funding.

[makinezmoney]

$TZPC: Gotta keep Vaccines super-cold during DISTRIBUTION


Now you know why we still going higher ?????



GO $TZPC

[lowfloatmaster]

TZPC STILL HUGE MARKET CAP, BUT NICE RUNNER
RDVA- SAME INDUSTRY MORE CLIENTS . 10MILL AS 5MILL OS 1MILL FLOAT.
IVE OWNRD THIS ONE FROM WAYYY BACK, COMING TO LIFE
MULTI RUNNER IMHO

[makinezmoney]

$TZPC: Moderna's Vaccine approved............ Requires Refrigeration


Moderna Announces Longer Shelf Life for its COVID-19 Vaccine Candidate at Refrigerated Temperatures MRNA 

****************************************************

Vaccine candidate now expected to remain stable at standard refrigerator temperatures of 2deg to 8degC (36deg to 46degF) for 30 days, up from previous estimate of 7 days

Shipping and long-term storage conditions at standard freezer temperatures of -20degC (-4degF) for 6 months

mRNA-1273 to be distributed using widely available vaccine delivery and storage infrastructure

No dilution required prior to vaccination

CAMBRIDGE, Mass.--(BUSINESS WIRE)--November 16, 2020--

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced new data showing that mRNA-1273, its COVID-19 vaccine candidate, remains stable at 2deg to 8degC (36deg to 46degF), the temperature of a standard home or medical refrigerator, for 30 days. Stability testing supports this extension from an earlier estimate of 7 days. mRNA-1273 remains stable at -20deg C (-4degF) for up to six months, at refrigerated conditions for up to 30 days and at room temperature for up to 12 hours.

"We believe that our investments in mRNA delivery technology and manufacturing process development will allow us to store and ship our COVID-19 vaccine candidate at temperatures commonly found in readily available pharmaceutical freezers and refrigerators," said Juan Andres, Chief Technical Operations and Quality Officer at Moderna. "We are pleased to submit these extended stability conditions for mRNA-1273 to regulators for approval. The ability to store our vaccine for up to 6 months at -20deg C including up to 30 days at normal refrigerator conditions after thawing is an important development and would enable simpler distribution and more flexibility to facilitate wider-scale vaccination in the United States and other parts of the world."

Shipping & Long-term Storage: For shipping and longer-term storage, Moderna expects that mRNA-1273 will be maintained at -20degC (-4degF), equal to most home or medical freezer temperatures, for up to 6 months. Using standard freezer temperatures of -20degC (range of -25deg to -15degC or -13deg to 5degF) is an easier and more established method of distribution and storage than deep freezing and most pharmaceutical distribution companies have the capability to store and ship products at -20degC (-4degF) worldwide.

Refrigeration Storage: After thawing, to facilitate storage at points of administration, Moderna expects that mRNA-1273 will remain stable at standard refrigerated conditions of 2deg to 8degC (36deg to 46degF) for up to 30 days within the 6-month shelf life. The stability at refrigerated conditions allows for storage at most pharmacies, hospitals, or physicians' offices.

Room Temperature for Vaccination: Once the vaccine is removed from the refrigerator for administration, it can be kept at room temperature conditions for up to 12 hours.

No Dilution Required at Vaccination Site: The vaccine will not require onsite dilution or special handling, which facilitates vaccination across a range of settings including pharmacies and physicians' offices.

The Company anticipates that it will continue to gather additional stability information over the coming months to assess whether mRNA-1273 can be shipped and stored under increasingly flexible conditions, which will be described in detail following regulatory approval.

The mRNA-1273 COVID-19 vaccine candidate is Moderna's tenth mRNA vaccine to enter the clinic. With its experience in prophylactic vaccine development and investments in mRNA platform and delivery technology, Moderna has developed enhanced manufacturing processes, resulting in proprietary lipid nanoparticle technology that Moderna believes will enable the vaccine to be stored at standard pharmaceutical distribution temperatures.

Moderna is working with the U.S. Centers for Disease Control and Prevention (CDC), Operation Warp Speed and McKesson (NYSE: MCK), a COVID-19 vaccine distributor contracted by the U.S. government, as well as global stakeholders to be prepared for distribution of mRNA-1273, in the event that it receives an Emergency Use Authorization and/or similar global authorizations. The Company is also working closely with the U.S. Food and Drug Administration (FDA) to submit data from its ongoing stability testing for approval.

About mRNA-1273

mRNA-1273 is an mRNA vaccine against COVID-19 encoding for a prefusion stabilized form of the Spike (S) protein, which was co-developed by Moderna and investigators from NIAID's Vaccine Research Center. The first clinical batch, which was funded by the Coalition for Epidemic Preparedness Innovations, was completed on February 7, 2020 and underwent analytical testing; it was shipped to the NIH on February 24, 42 days from sequence selection. The first participant in the NIAID-led Phase 1 study of mRNA-1273 was dosed on March 16, 63 days from sequence selection to Phase 1 study dosing. On May 12, the FDA granted mRNA-1273 Fast Track designation. On May 29, the first participants in each age cohort: adults ages 18-55 years (n=300) and older adults ages 55 years and above (n=300) were dosed in the Phase 2 study of mRNA-1273. On July 8, the Phase 2 study completed enrollment.

Results from the second interim analysis of the NIH-led Phase 1 study of mRNA-1273 in the 56-70 and 71+ age groups were published on September 29 in The New England Journal of Medicine. On July 28, results from a non-human primate preclinical viral challenge study evaluating mRNA-1273 were published in The New England Journal of Medicine. On July 14, an interim analysis of the original cohorts in the NIH-led Phase 1 study of mRNA-1273 was published in The New England Journal of Medicine. mRNA-1273 currently is not approved for use by any regulatory body.

BARDA is supporting the continued research and development of mRNA-1273 with $955 million in federal funding under Contract no. 75A50120C00034. BARDA is reimbursing Moderna for 100 percent of the allowable costs incurred by the Company for conducting the program described in the BARDA contract. The U.S. government has agreed to provide up to $1.525 billion to purchase supply of mRNA-1273 under U.S. Department of Defense Contract No. W911QY-20-C-0100.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including regarding the Company's development of a potential vaccine (mRNA-1273) against the novel coronavirus, the conditions under which mRNA-1273 can be shipped, stored and administered, and the U.S. government's potential purchases of mRNA-1273. In some cases, forward-looking statements can be identified by terminology such as "will," "may," "should," "could", "expects," "intends," "plans," "aims," "anticipates," "believes," "estimates," "predicts," "potential," "continue," or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. The forward-looking statements in this press release are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond Moderna's control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements. These risks, uncertainties, and other factors include, among others: the fact that there has never been a commercial product utilizing mRNA technology approved for use; the fact that the rapid response technology in use by Moderna is still being developed and implemented; the fact that the safety and efficacy of mRNA-1273 has not yet been established; despite having ongoing interactions with the FDA or other regulatory agencies, the FDA or such other regulatory agencies may not agree with the Company's regulatory approval strategies, components of our filings, such as clinical trial designs, conduct and methodologies, or the sufficiency of data submitted; potential adverse impacts due to the global COVID-19 pandemic such as delays in regulatory review, manufacturing and clinical trials, supply chain interruptions, adverse effects on healthcare systems and disruption of the global economy; and those other risks and uncertainties described under the heading "Risk Factors" in Moderna's most recent Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (SEC) and in subsequent filings made by Moderna with the SEC, which are available on the SEC's website at www.sec.gov. Except as required by law, Moderna disclaims any intention or responsibility for updating or revising any forward-looking statements contained in this press release in the event of new information, future developments or otherwise. These forward-looking statements are based on Moderna's current expectations and speak only as of the date hereof.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201116005606/en/

CONTACT: Moderna Contacts

Media:

Colleen Hussey

Director, Corporate Communications

617-335-1374

[e-mail]

Investors:

Lavina Talukdar

Senior Vice President & Head of Investor Relations

617-209-5834

[e-mail]

SOURCE: Moderna, Inc.

Copyright Business Wire 2020

> Dow Jones Newswires

November 16, 2020 06:52 ET (11:52 GMT)

[dieseld28]

Yea but anything under $4 is a gift imo there was plenty times ask was less than that

[ROCKY LEDGE]

I slap the ask every time on tight spreads. Won't slap a spread this wide! Get's to messy when getting out. Imho.

[dieseld28]

Just slap the asssskkk

[ROCKY LEDGE]

....of course it didn't. Spread to wide....won't fill. Ha hee!!

[ROCKY LEDGE]

TZPC.....try to trade it. PoopinG.

[dieseld28]

$10 for starters nice close

[makinezmoney]

$TZPC: Is $10 for Monday too much to ask ?


Asking for a friend.


HAVE A GREAT WEEKEND !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!



GO $TZPC

[makinezmoney]

$TZPC: When you transport Vaccines in a YETI...........


And you need something to cool it with, whatcha gonna use ??????


Think hard.


GO $TZPC

[makinezmoney]

$TZPC: Almost $300k worth traded today.............


ON something hardly anyone cares to pay attention to.


Guess who's not complaining ?


Whats my name ??????

[WHITTENHALLJR]

I’ve had a partial order in at 23 for hours >>> ask not budging

[makinezmoney]

$TZPC: Already found the one for next week..........



Same space as TZPC.... refrigeration.



$LTMP



GO $TZPC

[tiger3]

Up not much just 10000% a week.
Looking for next grand salami

[dieseld28]

Could go like SECI hit $75 a share

[makinezmoney]

$TZPC: Hit my $5 target...........


I'm as happy as a drunk at a bar




GO $TZPC

[cameron86]

About ready for the next leg.

[Awl416]

Now CDEL has another one at 4.25

[Awl416]

Pretty wild

[makinezmoney]

$TZPC: Did I call it..... or did i Call-IT ????????????



https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159459078



YAHHHHHHHHHOooooooooooooooooooooooooooooooooooooo



BLOODY AWESOME DAY !!!!!!!!!



$NATUF is next



GO $TZPC

[makinezmoney]

$TZPC: Guess who's going next after $TZPC ????????


Only $NATUF



GO $TZPC

[makinezmoney]

$TZPC: Now $4........... no stopping it now




GO $TZPC

[cameron86]

Holy bid

[Awl416]

And to think someone gave me 1000 shares at .99 yesterday

[makinezmoney]

$TZPC: Do you have any clue how much I'm making ????????????



HOllllllllyyyyyyyyyyyyyyyyyyyyyyyyy SHITTTTTTTTTTTTTTTTTTTTTT




GO $TZPC

[makinezmoney]

$TZPC: NOW $3.75 !!!!!!!!!!


What the WHATTTTTttttttttttttttttttttttttttttttttt ??????????????????



See that $75 on the ASK ??????????


I told you



GO $TZPC

[makinezmoney]

$TZPC: Now $2.95 !!!!!!!!!!!!!



HAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA




SMILE BITCH !!!!!!



GO $TZPC

[makinezmoney]

$TZPC: Now $2.25 !!!!!!!!!!!!!!!!


From $0.05 on MONDAY !!!!!!!!!!!!


How you like dem apples ???????????/


GO $TZPC

[cameron86]

Very possible . Level 2 is clear there and beyond.

[makinezmoney]

$TZPC: You just can't make this up............


See y'all on the big runup on $NATUF next !!!!!







GO $TZPC

[makinezmoney]

$TZPC: $5 tomorrow ???????????


I'll take it.


Guess who made $100k on $WSGF this week ???????????


https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159408366


And when that happens, more profits going directly into $NATUF



GO $TZPC

[makinezmoney]

$TZPC: Only $0.05 on Monday.... now 1.45 ???????


Can you see these from a MILE away like me yet or not ????????



Guess whos next.................. $NATUF


People who call these tickers dead are IDIOTS !!!!!!!!!!







GO $TZPC

[makinezmoney]

$TZPC: Now hitting $1.46 ..... HAAAAAAAaaaaaaaaa ha ha !!!!!!!!



Whats my name ?????????????


Don't tell me I didn't give $NATUF as a FREEBIE ... cuz I did.

[makinezmoney]

$TZPC: Do you see that $75 on the ASK ???????????


WHOOoooollllllllllyyyyyyyyyyyyyyy crap !!!!!!!


Got the next one lined up that has a similar make up



$POSAF



Still just sitting their pretty and the L2 so clean and open on the ask.


I love the way these things setup so sweet.



GO $TZPC

[cameron86]

Thank you! We can’t be the only ones holding this .. couple large smacks we go way higher..

[makinezmoney]

$TZPC: $1 just hit............. thank you !


GO $TZPC

[cameron86]

Appears that ways looks like it wants to go multiple dollars wow.. hold em!

[makinezmoney]

$TZPC: Whats even greater is........ No one knows


About it.


I've been here forever by myself.


Sitting on 300k shares :)



GO TZPC